White Matter in Pediatric Bipolar Disorder: A DTI Study
White Matter Connectivity in Pediatric Bipolar Disorder: A Diffusion Tensor Imaging Study
1 other identifier
observational
28
1 country
1
Brief Summary
Fourteen subjects with bipolar disorder and 14 matching healthy controls, aged 6-13, will receive a magnetic resonance imaging (MRI) scan on a 3 Tesla scanner. They will also have a clinical interview, including the KSADS-PL. All subjects must be right-handed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2005
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 19, 2006
CompletedFirst Posted
Study publicly available on registry
October 23, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedDecember 6, 2010
December 1, 2010
3 years
October 19, 2006
December 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fractional anisotropy in brain white matter
Baseline
Study Arms (2)
BPD
Children with bipolar disorder
HC
Healthy comparison children
Eligibility Criteria
Bipolar Disorder
You may qualify if:
- Age 6 to 13
- Male or female
- Right-handed
You may not qualify if:
- IQ less than 70
- Learning disabilities
- History of autism, schizophrenia, anorexia or bulimia nervosa
- Substance abuse
- Claustrophobia
- Metal in body
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cambridge Health Alliancelead
- American Academy of Child Adolescent Psychiatry.collaborator
- Eli Lilly and Companycollaborator
Study Sites (1)
Cambridge Health Alliance
Medford, Massachusetts, 02155, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean A Frazier, MD
Cambridge Health Alliance
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 19, 2006
First Posted
October 23, 2006
Study Start
September 1, 2005
Primary Completion
September 1, 2008
Study Completion
October 1, 2008
Last Updated
December 6, 2010
Record last verified: 2010-12